STU · Other
Other
AGIOS PHARM (8AP.SG) (8AP) is listed on STU in the Other sector. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
The price-to-earnings (P/E) ratio for AGIOS PHARM (8AP.SG) (8AP) is 18.00 (data as of 2026-03-24).
Dividend yield is not available in the current snapshot for AGIOS PHARM (8AP.SG) (8AP). Check the MyAverix Finance app for the latest dividend data.
AGIOS PHARM (8AP.SG) (8AP) is classified in the Other sector.
8AP is listed on STU.
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.